Ratings Emak S.p.A.

Equities

EM

IT0001237053

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-04-26 am EDT			5-day change	1st Jan Change
1.08 ^EUR	-1.64%		+1.89%	-1.64%

Mar. 19	Bioera tops post-accounts; goes down Restart	AN
Mar. 15	Giuliano Ferrari buys 20,000 shares in Emak	AN

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

Its low valuation, with P/E ratio at 6.71 and 5.68 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company shows low valuation levels, with an enterprise value at 0.59 times its sales.
The company's share price in relation to its net book value makes it look relatively cheap.
The company has a low valuation given the cash flows generated by its activity.
The company is one of the best yield companies with high dividend expectations.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the past twelve months, EPS forecast has been revised upwards.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Heavy Machinery & Vehicles

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
EMAK S.P.A.	-1.64%	188M		C
DEERE & COMPANY	-1.64%	109B		B+
THE TORO COMPANY	-8.84%	9.14B		B
ESCORTS KUBOTA LIMITED	+10.34%	4.35B		C-
TÜRK TRAKTÖR VE ZIRAAT MAKINELERI	+27.11%	2.79B		A-
FIRST TRACTOR COMPANY LIMITED	+64.52%	2.27B	-	-
LINDSAY CORPORATION	-10.00%	1.28B		B-
AG GROWTH INTERNATIONAL INC.	+18.94%	834M		C
TÜMOSAN MOTOR VE TRAKTÖR SANAYI	+102.98%	603M	-	-
YAMABIKO CORPORATION	+39.37%	546M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes